Kaye Alan D, Hoover Jason M, Kaye Aaron J, Ibrahim Ikhlass N, Phelps James, Baluch Amir
Department of Anesthesiology, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.
Am J Ther. 2007 May-Jun;14(3):247-52. doi: 10.1097/01.mjt.0000208877.46233.13.
There are extensive data on roles of cyclooxygenase 1 (COX 1) and cyclooxygenase 2 (COX 2) enzymes in temperature, coagulation, and inflammatory modulation. There is little known of the function of these enzymes in regulating tone in pulmonary vasculature. The purpose of this investigation was to elucidate the roles of COX 1 and 2 enzymes in the feline pulmonary vascular bed.
Prospective vehicle controlled study.
University research laboratory.
Intact chest preparation; adult mongrel cats.
The effects of intravascular administration of U46619, angiotensin II, prostaglandin E1 (PGE1), arachidonic acid, and norepinephrine, were analyzed before and after intravascular administration of selective COX enzyme inhibitors.
Because lobar arterial flow is constant in these experiments, changes in lobar pressure represent changes in pulmonary arterial resistance. Under constant flow conditions, lobar arterial and systemic pressures were continuously monitored, electronically averaged, and recorded. In the isolated left lower lobe of the feline lung bed, U46619, angiotensin II, arachidonic acid, and norepinephrine induced a dose-dependent vasoconstrictor response. PGE1 induced a dose-dependent vasodepressor response. After administration of the COX 1 inhibitor SC 560, the arachidonic acid-induced vasopressor responses were significantly attenuated while U46619, angiotensin II, and norepinephrine-induced vasopressor, and PGE1-induced vasodepressor responses were not significantly altered. After administration of the COX 2 inhibitor nimesulide, both the PGE 1 vasodepressor responses and arachidonic acid-induced vasopressor responses were significantly decreased while the U46619, angiotensin II, and norepinephrine-induced vasopressor responses were not significantly attenuated.
The results of the study indicate that PGE1 has potent vasodepressor effects in the feline lung bed and this response is mediated by COX 2 pathways. The data also suggest that arachidonic acid has potent vasopressor activity in the feline pulmonary vascular bed and this response is mediated by both COX 1 and COX 2 sensitive pathways.
关于环氧化酶1(COX 1)和环氧化酶2(COX 2)在体温、凝血及炎症调节中的作用,已有大量数据。但对于这些酶在调节肺血管张力方面的功能却知之甚少。本研究的目的是阐明COX 1和COX 2在猫肺血管床中的作用。
前瞻性载体对照研究。
大学研究实验室。
完整胸腔制备;成年杂种猫。
在血管内给予选择性COX酶抑制剂前后,分析血管内给予U46619、血管紧张素II、前列腺素E1(PGE1)、花生四烯酸和去甲肾上腺素的效果。
由于在这些实验中肺叶动脉血流恒定,肺叶压力的变化代表肺动脉阻力的变化。在恒定血流条件下,持续监测肺叶动脉和全身压力,进行电子平均并记录。在猫肺床的离体左下叶中,U46619、血管紧张素II、花生四烯酸和去甲肾上腺素诱导剂量依赖性血管收缩反应。PGE1诱导剂量依赖性血管舒张反应。给予COX 1抑制剂SC 560后,花生四烯酸诱导的血管升压反应显著减弱,而U46619、血管紧张素II和去甲肾上腺素诱导的血管升压反应以及PGE1诱导的血管舒张反应未显著改变。给予COX 2抑制剂尼美舒利后,PGE1血管舒张反应和花生四烯酸诱导的血管升压反应均显著降低,而U46619、血管紧张素II和去甲肾上腺素诱导的血管升压反应未显著减弱。
研究结果表明,PGE 在猫肺床具有强大的血管舒张作用,且该反应由COX 2途径介导。数据还提示,花生四烯酸在猫肺血管床具有强大的血管升压活性,且该反应由COX 1和COX 2敏感途径介导。